Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.

BACKGROUND Herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) are common infections with serious sequelae. HSV-1 is an increasingly important cause of genital herpes in industrialized countries. METHODS Using nationally representative data from the National Health and Nutrition Examination Survey (NHANES), we examined HSV-1 and HSV-2 seroprevalence among 14- to 49-year-olds in the United States. We estimated seroprevalence in 1999-2004 and 2005-2010, stratified by sociodemographic characteristics and sexual behaviors. We also reviewed HSV-1 and HSV-2 seroprevalence from 1976-1980 to 2005-2010. RESULTS In 2005-2010, the seroprevalence of HSV-1 was 53.9%, and the seroprevalence of HSV-2 was 15.7%. From 1999-2004 to 2005-2010, HSV-1 seroprevalence declined by nearly 7% (P < .01), but HSV-2 seroprevalence did not change significantly. The largest decline in HSV-1 seroprevalence from 1999-2004 to 2005-2010 was observed among adolescents aged 14-19 years, among whom seroprevalence declined by nearly 23%, from 39.0% to 30.1% (P < .01). In this age group, HSV-1 seroprevalence declined >29% from 1976-1980 to 2005-2010 (P < .01). CONCLUSIONS An increasing number of adolescents lack HSV-1 antibodies at sexual debut. In the absence of declines in HSV-2 infections, the prevalence of genital herpes may increase.

[1]  A. McNulty,et al.  Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992–2006 , 2009, Sexually Transmitted Infections.

[2]  J. Schillinger,et al.  National Seroprevalence and Trends in Herpes Simplex Virus Type 1 in the United States, 1976–1994 , 2004, Sexually transmitted diseases.

[3]  A. Nahmias,et al.  A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies. , 1986, Journal of virological methods.

[4]  G. Mcquillan,et al.  Herpes simplex virus type 2 in the United States, 1976 to 1994. , 1998, The New England journal of medicine.

[5]  G. Martinez,et al.  Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006-2010 national survey of family growth. , 2011, Vital and health statistics. Series 23, Data from the National Survey of Family Growth.

[6]  E L Korn,et al.  Epidemiologic studies utilizing surveys: accounting for the sampling design. , 1991, American journal of public health.

[7]  Fujie Xu,et al.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. , 2006, JAMA.

[8]  R L Ashley,et al.  Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera , 1988, Journal of clinical microbiology.

[9]  J. Ilonen,et al.  Development of Antibodies Against Cytomegalovirus, Varicella-zoster Virus and Herpes Simplex Virus in Finland During the First Eight Years Of Life: A Prospective Study , 2003, Scandinavian journal of infectious diseases.

[10]  J. Ickovics,et al.  Racial/Ethnic Disparities in Undiagnosed Infection With Herpes Simplex Virus Type 2 , 2010, Sexually transmitted diseases.

[11]  Takashi Kawana,et al.  [Genital herpes]. , 2009, Nihon rinsho. Japanese journal of clinical medicine.

[12]  W. Leong,et al.  A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. , 1999, The New England journal of medicine.

[13]  D. Bernstein,et al.  Efficacy results of a trial of a herpes simplex vaccine. , 2012, The New England journal of medicine.

[14]  R. M. Coleman,et al.  Detection of herpes simplex virus type 2-specific antibody with glycoprotein G , 1985, Journal of clinical microbiology.

[15]  A. Chandra,et al.  Prevalence and timing of oral sex with opposite-sex partners among females and males aged 15-24 years: United States, 2007-2010. , 2012, National health statistics reports.

[16]  H. D. de Melker,et al.  The seroepidemiology of herpes simplex virus type 1 and 2 in Europe , 2004, Sexually Transmitted Infections.

[17]  Massey Jt,et al.  Design and estimation for the National Health Interview Survey 1985-94. , 1989 .

[18]  F. Aoki,et al.  Glycoprotein-D-adjuvant vaccine to prevent genital herpes. , 2002, The New England journal of medicine.

[19]  N. Gay,et al.  The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes , 2000, Sexually transmitted infections.

[20]  Jack R. Anderson.  Design and estimation for the National Health Interview Survey, 1995-2004. , 2000, Vital and health statistics. Series 2, Data evaluation and methods research.

[21]  M. Gilbert,et al.  Using Centralized Laboratory Data to Monitor Trends in Herpes Simplex Virus Type 1 and 2 Infection in British Columbia and the Changing Etiology of Genital Herpes , 2011, Canadian journal of public health = Revue canadienne de sante publique.

[22]  Gary Dubin,et al.  Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  T. Quinn,et al.  Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda. , 2004, The Journal of infectious diseases.

[24]  A. Wald.  Genital HSV-1 infections , 2006, Sexually Transmitted Infections.

[25]  Craig M. Roberts,et al.  Increasing Proportion of Herpes Simplex Virus Type 1 as a Cause of Genital Herpes Infection in College Students , 2003, Sexually transmitted diseases.

[26]  Richard J Hayes,et al.  Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies , 2006, AIDS.

[27]  T. Scheper,et al.  Seroprevalence of herpes simplex virus type 1 and type 2 in Thuringia, Germany, 1999 to 2006. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[28]  Z. Samra,et al.  Herpes Simplex Virus Type 1 Is the Prevailing Cause of Genital Herpes in the Tel Aviv Area, Israel , 2003, Sexually transmitted diseases.

[29]  Robert E. Johnson,et al.  Herpes Simplex Virus Type 2 in the United States, 1976 to 1994 , 1997 .